Clinical Trials Logo
  1. Home
  2. Failure to Thrive
  3. NCT02879357

Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients — iCMP  

Failure to Thrive Clinical Trial

Official title:
Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients

Clinical Trial Summary

The hypothesis of the Serious Illness Care Program (SICP) is that adherence to the Serious Illness Conversation Guide (SICG) portion, the SIGC, will enhance patient understanding and allow control over their own decisions, relieve burdens of decision-making on family members, and help patients achieve a state of peace as they approach the end of life.

Clinical Trial Description

The aim of the Serious Illness Care Program (SICP) is to provide clinicians with an evidence-based structure for eliciting and documenting vital information about preferences for patient driven care of their serious illness. It is designed to help open the door for patients, families, and clinicians to talk and reflect on end-of-life issues in an ongoing way. The hypothesis of the Serious Illness Care Program is that adherence to the conversation guide portion, the SIGC, will enhance patient understanding and allow control over their own decisions, relieve burdens of decision-making on family members, and help patients achieve a state of peace as they approach the end of life. For this protocol specifically, the investigators are testing a pilot intervention of a quality improvement project; the investigators plan to train clinicians and assess the feasibility and impact of the Serious Illness Care Program, which includes patient identification, clinician training, "triggering" of clinicians to conduct the SICG conversation, and documentation, in the iCMP at the Brigham and Women's Hospital. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02879357
Study type Interventional
Source Brigham and Women's Hospital
Contact
Status Completed
Phase N/A
Start date March 2014
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT05289674 - The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection N/A
Completed NCT05333133 - High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children N/A
Completed NCT03202576 - Nasogastric Tube Securement Comparison Study N/A
Completed NCT01338363 - Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists N/A
Completed NCT04393909 - Improving Safety of Diagnosis and Therapy in the Inpatient Setting N/A
Not yet recruiting NCT01772927 - Clinical Tolerance of Numeta 13% N/A
Completed NCT02128984 - Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children N/A
Completed NCT01070173 - Ghrelin Levels in Children With Poor Growth N/A
Completed NCT00483691 - Trial of Home Visitation Among Infants With Failure To Thrive N/A
Completed NCT00190658 - Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome Phase 3
Completed NCT02647580 - Appetite Regulation in Children With Failure to Thrive N/A
Recruiting NCT01314989 - Cyproheptadine as an Appetite Stimulant Phase 4
Completed NCT00001639 - Evaluation of Patients With Unresolved Chromosome Abnormalities N/A
Completed NCT04985227 - Impact of Home Weight Tele-monitoring on the Number of Office Visits in the First Six Weeks of Life in Infants. N/A
Terminated NCT02589132 - Mobile-Thrive - A Family Self-Management Approach to Failure to Thrive N/A
Terminated NCT02710383 - Biomarker for Cystic Fibrosis
Completed NCT00325611 - Multidisciplinary Inpatient Palliative Care Intervention N/A